Results 81 to 90 of about 32,848 (294)

Single Center Experience With Hyperthermic Intraperitoneal Chemotherapy [PDF]

open access: yesAnnals of Coloproctology, 2017
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been proposed for controlling peritoneal seeding metastasis in some kinds of cancers, including those of colorectal origin, but their safety and oncological benefits are subjects of debate.
Kim, Woo Ram   +5 more
openaire   +3 more sources

The role of cytokines in ovarian cancer drug resistance

open access: yesInternational Journal of Cancer, Volume 158, Issue 4, Page 821-834, 15 February 2026.
Abstract Ovarian cancer is the leading cause of death among women diagnosed with female reproductive system cancers. While significant advances have been made in treating various types of cancer, progress in ovarian cancer treatment over the past 20 years has been minimal, and the treatment course of ovarian cancer is not linear. Although many patients
Lu Wang   +7 more
wiley   +1 more source

Regional hyperthermia of the abdomen, a pilot study towards the treatment of peritoneal carcinomatosis [PDF]

open access: yes, 2015
Background Peritoneal carcinomatosis occurs in different cancer subtypes and is associated with a dismal prognosis. Some doubts remain whether the whole abdomen can be treated by regional hyperthermia, therefore we analyzed feasibility conducting a pilot
Beck, Marcus   +7 more
core   +2 more sources

The Registry of Hyperthermic Intraperitoneal Chemotherapy – A Mandatory Step in the Development of this Therapeutic Approach in Romania

open access: yesApplied Medical Informatics, 2015
Multicenter/institutional studies have been the basis for the confirmation of Hyperthermic Intraperitoneal Chemotherapy as a therapeutic option for selected patients with Peritoneal Surface Malignancies.
Corneliu LUNGOCI   +5 more
doaj  

Pediatric peri-operative fractionated high-dose-rate brachytherapy for recurrent Wilms’ tumor using a reconstructed Freiburg flap

open access: yesJournal of Contemporary Brachytherapy, 2016
Purpose : To report peri-operative fractionated high-dose-rate (HDR) brachytherapy with a 3D customized Freiburg flap applicator to treat locally recurrent Wilms’ tumor, followed by immediate hyperthermic intraperitoneal chemotherapy for a 16-year-old ...
Emily Flower   +7 more
doaj   +1 more source

Neoadjuvant chemotherapy followed by hyperthermic intraperitoneal chemotherapy for patients with colorectal peritoneal metastasis: a retrospective study of its safety and efficacy

open access: yesWorld Journal of Surgical Oncology, 2021
Background Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) are effective routine treatments for colorectal peritoneal metastasis (PM).
Sicheng Zhou   +4 more
semanticscholar   +1 more source

Prognostic Factors and Nomogram‐Based Prediction Models for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis Undergoing Cytoreductive Surgery: A Retrospective Cohort Study

open access: yesCancer Medicine, Volume 15, Issue 1, January 2026.
ABSTRACT Background Colorectal cancer (CRC) with synchronous peritoneal metastasis (SPM) presents poor prognosis and complex treatment challenges. This study aimed to identify independent prognostic factors and develop nomogram‐based prediction models for overall survival (OS) and progression‐free survival (PFS) in CRC patients with SPM (CRC‐SPM ...
Xiaoxu Ge   +11 more
wiley   +1 more source

Hyperthermic intraperitoneal chemotherapy in colorectal cancer

open access: yesBJS Open
Abstract Background This study evaluated the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer with peritoneal metastases (pmCRC) in a large international data set of patients.
Oliver M Fisher   +58 more
openaire   +5 more sources

Advances in the Treatment of Colorectal Cancer with Peritoneal Metastases: A Focus on Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

open access: yesThe Ewha Medical Journal, 2023
In stage IV colorectal cancer (CRC), peritoneal metastasis is associated with a poor prognosis. Hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery (CRS) is an effective treatment option ...
Youngbae Jeon, Eun Jung Park
doaj   +1 more source

Cytoreductive Surgery With or Without Hyperthermic Intraperitoneal Chemotherapy for Gastric Cancer With Peritoneal Metastases (CYTO-CHIP study): A Propensity Score Analysis.

open access: yesJournal of Clinical Oncology, 2019
PURPOSE Gastric cancer (GC) with peritoneal metastases (PMs) is a poor prognostic evolution. Cytoreductive surgery (CRS) yields promising results, but the impact of hyperthermic intraperitoneal chemotherapy (HIPEC) remains controversial. Here we aimed to
P. Bonnot   +24 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy